yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q26776225-5D988683-6E2D-4F78-AD9E-5051407AAA7C
Q26776225-5D988683-6E2D-4F78-AD9E-5051407AAA7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26776225-5D988683-6E2D-4F78-AD9E-5051407AAA7C
Future perspectives in target-specific immunotherapies of myasthenia gravis
P2860
Q26776225-5D988683-6E2D-4F78-AD9E-5051407AAA7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26776225-5D988683-6E2D-4F78-AD9E-5051407AAA7C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b3cddc98a35c6683b92bd77e0cd0d04358ee8a89
P2860
Vedolizumab as induction and maintenance therapy for ulcerative colitis.